Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05114538 · ClinicalTrials.gov registry record · NA
Improving the Part C Early Intervention Service Delivery System for Children with ASD
A NA study of Autism Spectrum Disorder, sponsored by University of Washington.
- Recruiting
- Registry status
- NA
- Development phase
- 440
- Enrollment target
- 4
- Study locations
NCT05114538: Recruiting NA study of Autism Spectrum Disorder, sponsored by University of Washington.
NCT05114538 is a NA study of Autism Spectrum Disorder that is actively recruiting participants, run by University of Washington. The registered enrollment target is 440 participants, above the 133-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (231% higher). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05114538, a NA study of Autism Spectrum Disorder, is actively recruiting participants, sponsored by University of Washington.
- RECRUITING
- Registry status
- NA
- Development phase
- 440 participants
- Enrollment target
- 4
- Study locations
Study Summary
Despite strong consensus that early, specialized intervention for children with autism spectrum disorder (ASD) can have a dramatic impact on outcomes, the public health system's capacity to provide such services is severely challenged by the rapid rise in ASD prevalence. The goal of this research project is to increase timely and equitable access to ASD-specialized early intervention during the critical first three years of life by capitalizing on the existing infrastructure of the Part C Early Intervention (EI) system, which is publicly funded and available in all states in the United States. This project will train EI providers to use an evidence-based, parent-mediated intervention that can improve child and family outcomes as well as mitigate the long-term substantial economic costs associated with ASD.
Primary Outcome
An adapted version of the UIA coding protocol (Ingersoll, 2012) will be used to measure spontaneous motor imitation within a virtual administration of an adapted version of the Communication Play Protocol (CPP; Adamson et al., 2004, Tagavi et al., 2025).
Conditions Studied
Interventions
- BEHAVIORAL Reciprocal Imitation Training
Study Locations (4)
Illinois
- Rush University Medical Center - Chicago
Massachusetts
- University of Massachusetts Boston - Boston
Michigan
- Michigan State University - East Lansing
Washington
- Carol A Schubert - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 440 participants |
| Start Date | 2021-09-27 |
| Est. Completion | 2025-05-31 |
| Phase | NA |
What NCT05114538 shows while recruiting
NCT05114538 is an interventional study that assigns participants to a tested intervention. The registered 440 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (231% higher).
The record links to 1 condition, with Autism Spectrum Disorder appearing as the primary indexed condition, and to 1 intervention - of which Reciprocal Imitation Training is the first listed.
NCT05114538 reports a single indexed study location in Illinois, Massachusetts, Michigan.
Frequently Asked Questions
What is clinical trial NCT05114538 about?
NCT05114538 is a clinical study titled "Improving the Part C Early Intervention Service Delivery System for Children with ASD". Despite strong consensus that early, specialized intervention for children with autism spectrum disorder (ASD) can have a dramatic impact on outcomes, the public health system's capacity to provide such services is severely challenged by the rapid rise in ASD prevalence. The goal of this research pr...
What is the current status of trial NCT05114538?
This trial is currently recruiting. It is a NA study. The enrollment target is 440 participants. The study started on 2021-09-27. Estimated completion is 2025-05-31.
What conditions does trial NCT05114538 study?
This clinical trial studies the following conditions: Autism Spectrum Disorder.
What interventions are being tested in trial NCT05114538?
The interventions under investigation include: Reciprocal Imitation Training (BEHAVIORAL).
Who is sponsoring clinical trial NCT05114538?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05114538 being conducted?
This trial has 4 study locations across Illinois, Massachusetts, Michigan, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Autism Spectrum Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05114538's enrollment target sits among peer trials
440 16th of 224 higher than 209 of 224 other Autism Spectrum Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Autism Spectrum Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
COMPASS Across Settings (CAST) for Improving Transition Outcomes for Students With ASD
RECRUITING · NA
-
Emergent Multi-Class Imitation Training
RECRUITING · NA
-
Physical Activity and Community EmPOWERment Project
RECRUITING · NA
-
Online Pivotal Response Treatment Training in Autism Spectrum Disorder
RECRUITING · NA
-
Cerebellum and Autism: Regional Specialization for Social and Executive Functions
RECRUITING · NA
-
Milieu Teaching-AV (MT-AV Pilot)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05117619 · 440 participants · NA
The HOME Program for Individuals With Traumatic Brain Injury and Family Members
- NCT05602194 · 440 participants · Phase 3
Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma
- NCT05624879 · 440 participants · NA
Accelerated Resolution Therapy for Early Maladaptive Grief
- NCT05783635 · 440 participants · NA
Alcohol Screening and Preoperative Intervention Research Study - 2
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI